Akari Therapeutics, Plc (AKTX)
USD 0.96
(-3.99%)
USD 0.96
(-3.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.43 Million | -21.5 Million | -18.84 Million | -16.95 Million | -12.25 Million | -22.53 Million |
| Net Income | -10 Million | -17.74 Million | -17.42 Million | -20.45 Million | -24.75 Million | -23.5 Million |
| Depreciation & Amortization | 4000.00 | 3708.00 | 4126.00 | 8000.00 | 18 Thousand | 39 Thousand |
| Deferred income taxes | - | - | - | 2.85 Million | 2.98 Million | - |
| Stock-based compensation | 1.15 Million | 735 Thousand | 314.65 Thousand | 325.52 Thousand | 1.04 Million | 1.64 Million |
| Change in working capital | 70 Thousand | 821.89 Thousand | -1.98 Million | -2.91 Million | 8.27 Million | -619 Thousand |
| Other non-cash items | -7.64 Million | -5.31 Million | 242.5 Thousand | 3.22 Million | 169 Thousand | -105 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 7.02 Million | 25.28 Million | 14.29 Million | 25.07 Million | 11.98 Million | 306 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.02 Million | 25.19 Million | 14.29 Million | 25.91 Million | 11.79 Million | 891 Thousand |
| Other Financing Activities | 7.02 Million | 94.11 Thousand | 14.29 Thousand | -840 Thousand | 196 Thousand | -585 Thousand |
| Accounts receivables | - | 1.69 Million | - | - | - | - |
| Accounts payables | - | - | -241.3 Thousand | - | 2.38 Million | -3.68 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 70 Thousand | -877.1 Thousand | -1.74 Million | -2.91 Million | 5.89 Million | 3.07 Million |
| Cash at beginning of period | 13.25 Million | 9.36 Million | 14.05 Million | 5.73 Million | 5.96 Million | 28.24 Million |
| Cash at end of period | 3.84 Million | 13.24 Million | 9.36 Million | 14.05 Million | 5.73 Million | 5.96 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 7000.00 | 105.08 Thousand | -140.73 Thousand | 201 Thousand | 34 Thousand | -51 Thousand |
| Net cash flow / Change in cash | -9.4 Million | 3.88 Million | -4.69 Million | 8.32 Million | -236 Thousand | -22.28 Million |
| Free Cash Flow | -16.43 Million | -21.5 Million | -18.84 Million | -16.95 Million | -12.25 Million | -22.53 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.55 Million | -5.56 Million | -10 Million | -3504.70 | -3504.70 | -2.99 Million |
| Depreciation & Amortization | - | 12.99 Thousand | 4000.00 | 1.08 | 1.08 | 1849.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 445 Thousand | 296.00 | 1.15 Million | 304.24 | 304.24 | 270.76 |
| Change in working capital | 2.05 Million | 1.59 Million | -866 Thousand | 534.00 | 534.00 | -918.62 Thousand |
| Other non-cash items | 611.99 Thousand | -62.99 Thousand | -5.55 Million | -763.77 | -763.77 | -3.06 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 7.76 Million | 1.51 Million | 7.02 Million | 1758.58 | 1758.58 | 3.49 Million |
| Debt repayment | -669 Thousand | -215.00 | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.09 Million | 1.72 Million | 7.02 Million | - | - | 3.49 Million |
| Other Financing Activities | 666 Thousand | -212 Thousand | 7.02 Million | 1758.58 | 1758.58 | 1.75 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.05 Million | 1.59 Million | -866 Thousand | 534.00 | 534.00 | -499 Thousand |
| Cash at beginning of period | 1.31 Million | 3845.00 | 13.24 Million | 1.66 Million | 1.66 Million | 11.58 Thousand |
| Cash at end of period | 4.17 Million | 1.31 Million | 3.84 Million | -1667.87 | -1667.87 | 7.18 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -2000.00 | -5.00 | 7000.00 | 2.69 | 2.69 | 1614.00 |
| Net cash flow / Change in cash | 2.86 Million | 1.3 Million | -9.4 Million | -1.66 Million | -1.66 Million | 7.16 Million |
| Free Cash Flow | -4.89 Million | -4.04 Million | -16.43 Million | -3429.15 | -3429.15 | -9.56 Million |
BBTC
TCPI
BCGWW
TPIA
9342
RTNPOWER